Hoping to see this reach its funding goal soon! Had a chance to test it out. Tons of learning for ID trainees, or those interested in global health, public health, emerging infections and one health.

👉 10/20/25: 5-5:25pm TID fellows, Drs. Gabriel Motoa Cardona (Columbia Presbyterian-Cornell) and Stella Radosta (UT Southwestern) will each present a case, with discussions led by Drs. Alan Koff (UC Davis) and Alpana Waghmare (University of Washington/Fred Hutch)

News is all about H1B in the tech sector, but doesn’t mention how important that pathway is for IMG physicians. Imagine getting a residency program to sponsor an H1B for $100,000. This pathway will all but disappear except for high-paying specialty hires. Glad you made it back ok.

@maricarmalinis.bsky.social

Difference between ABC and TAF is less impressive than both of them compared to TDF. I've tended to get patients on two drug regimens without tenofovir where possible because of some of these metabolic syndrome concerns.

Study looks underpowered, numerically the rates of VRE infection were lower with VRE prophylaxis at all time points. Outcomes with tigecycline here may not translate to daptomycin either, given very different drug properties. Need larger datasets/multicenter retrospectives.

Are any HCWs at your site just wearing N95s all the time now? ER docs?

Ideally HSCT recipients should be able to rely on the general population for herd immunity from measles. It's unfortunate that this needs to be considered due to waning vaccination rates. Interesting paper though, thanks for sharing.

Identify what the trainee wants from the project. Research skills? Networking? Experience for residency / fellowship applications? Publication? The project scope and timeline will vary depending on their goal.

I do feel bad when they have to listen to all the history taking when all they want is to get a quick consent signed. But then they would never know the patient has a rescue dog named "Baxter" or that they worked in the traveling circus, so 🤷‍♂️